Amendment: Windtree Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

Form 8-K/A date of report 03-18-25 true 0000946486 0000946486 2025-03-18 2025-03-18

 

 

 

 

 

Date of Report (Date of earliest event reported): March 18, 2025

 

(Exact name of registrant as specified in its charter)

 

 

 

(Registrant’s telephone number, including area code)

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

On March 24, 2025, Windtree Therapeutics, Inc. filed a Current Report on Form 8-K (the “Original Report”) disclosing that it had issued a press release on March 20, 2025, which was to be attached as Exhibit 99.1. Exhibit 99.1 was inadvertently omitted in the Original Report. This Amendment No. 1 to Form 8-K (this “Amendment No. 1”), which amends the Original Report, is being filed solely to include Exhibit 99.1 that was omitted in the Original Report. Except as described herein, this Amendment No. 1 does not amend, update, or change any other items or disclosures in the Original Report.

 

 

The disclosures set forth in Item 7.01 of the Original Report are incorporated into this Amendment No. 1 by reference without changes, except that all references to Exhibit 99.1 in the Original Report refer to Exhibit 99.1 filed herewith.

 

 

(d) Exhibits.

 

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.